BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  OFC 2019 to Showcase Optical Innovations in Data Center Networks for Key Business Areas

  As data center traffic grows exponentially from cloud computing and applications including Artificial Intelligence (AI), data science and Internet of Things (IoT), the data center landscape is changing rapidly.

  February 6, 2019

   · 

  4 min read
• Business

  Apixio Promotes Healthcare Sales Veterans into Senior Positions

  Apixio Inc., a leading healthcare AI analytics company, today announced the promotion of two sales executives to senior positions.

  February 6, 2019

   · 

  2 min read
• Job Trends

  Vizient, Inc. Joins Other Health Care Leaders to Support the CREATES Act

  Vizient, Inc., joins more than 50 other health care leaders in voicing its strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

  February 6, 2019

   · 

  2 min read
• Pharm Country

  ELLKAY Showcases Interoperability & Innovation At HIMSS ’19

  ELLKAY, LLC, a recognized healthcare connectivity leader, announced plans to demonstrate its innovative new solutions at the Healthcare Information and Management Systems Society (HIMSS) 2019 Annual Conference & Exhibition, February 11-15, 2019 in Orlando, FL.

  February 6, 2019

   · 

  3 min read
• Policy

  Federal court enters consent decree against Ranier’s Rx Laboratory and owner for manufacturing purportedly sterile drug products in insanitary conditions

  Pennsylvania compounder prohibited from manufacturing and distributing sterile human and animal drug products

  February 6, 2019

   · 

  3 min read
• Pharm Country

  Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)

  Israel Parliament Approval is Expected to Catalyze Export of Medical Cannabis; ETCH Biotrace Solution Positioned as Safe and Secure Means to Manage the Legal Supply Chain for Export

  February 6, 2019

   · 

  5 min read
• Drug Development

  Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody with a Best-in-Class Profile

  Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of next-generation anti-CD47 antibody therapies for cancer, today announced the initiation of a new Phase 1 clinical trial of AO-176 in select solid tumors with the first patient dosed.

  February 6, 2019

   · 

  3 min read
• Business

  Vaxart Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

  Initiation of Two Norovirus Vaccine Trials Expected in 1H 2019

  February 6, 2019

   · 

  7 min read
• Business

  Aflac Incorporated to Present at the Bank of America Merrill Lynch 2019 Insurance Conference

  Aflac Incorporated announced that it will present at the Bank of America Merrill Lynch 2019 Insurance Conference.

  February 6, 2019

   · 

  5 min read
• Drug Development

  Takeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL – a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A– at EAHAD 2019

  The PROPEL study compared the safety and efficacy of ADYNOVATE® [Antihemophilic Factor [Recombinant], PEGylated] following pharmacokinetic (PK)-guided prophylaxis, targeting two different factor VIII trough levels

  February 6, 2019

   · 

  9 min read